Sanofi Kevzara Drug As COVID-19 Treatment Fails

TEHRAN ( Iran News ) – The rheumatoid arthritis drug Kevzara has failed as a COVID-19 treatment, French drugmaker Sanofi said on Tuesday following a similar flop of a Roche product. Sanofi said Kevzara – which it produces with partner Regeneron – had failed as a COVID-19 treatment after the latest set of trials in patients across the world showed adverse effects, and would be dropped for studies in this field. Sanofi said the trials had led in some cases to COVID-19 pneumonia infections and even death in a few cases, Reuters reported.